Your browser doesn't support javascript.
loading
Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
Cervantes, Francisco; Ross, David M; Radinoff, Atanas; Palandri, Francesca; Myasnikov, Alexandr; Vannucchi, Alessandro M; Zachee, Pierre; Gisslinger, Heinz; Komatsu, Norio; Foltz, Lynda; Mannelli, Francesco; Passamonti, Francesco; Gilotti, Geralyn; Sadek, Islam; Tiwari, Ranjan; Zor, Evren; Al-Ali, Haifa Kathrin.
Affiliation
  • Cervantes F; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. FCERVAN@clinic.cat.
  • Ross DM; Royal Adelaide Hospital and Flinders Medical Centre, Adelaide, SA, Australia.
  • Radinoff A; University Hospital Sveti Ivan Rislki, Sofia, Bulgaria.
  • Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology "Seràgnoli", Bologna, Italy.
  • Myasnikov A; Department of Hematology, V.A. Baranov Republican Hospital, Petrozavodsk, Russian Federation.
  • Vannucchi AM; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Zachee P; Hematology Service, ZNA Stuivenberg, Antwerp, Belgium.
  • Gisslinger H; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Komatsu N; Juntendo University School of Medicine, Tokyo, Japan.
  • Foltz L; St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Mannelli F; CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Passamonti F; University of Insubria, Varese, Italy.
  • Gilotti G; Novartis Pharma, East Hanover, NJ, USA.
  • Sadek I; Novartis Pharma, East Hanover, NJ, USA.
  • Tiwari R; Novartis Healthcare Pvt. Ltd, Hyderabad, India.
  • Zor E; Novartis Pharma AG, Basel, Switzerland.
  • Al-Ali HK; University Hospital Halle, Halle (Saale), Germany.
Leukemia ; 35(12): 3626, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34475521
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Type: Article Affiliation country: Spain